Exploratory/Developmental Bioengineering Research Grants (EBRG)

The National Cancer Institute (NCI) is seeking exploratory and developmental bioengineering research grant applications. This initiative aims to foster the demonstration of feasibility and potential utility of novel capabilities or improvements in the quality, speed, efficacy, operability, cost, and/or accessibility of solutions for basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility. This funding opportunity is open to a wide range of eligible applicants, including various serving institutions, federal agencies, faith-based or community-based organizations, tribal governments, non-U.S. entities, and for-profit organizations, including small businesses. The grants fall under the funding categories of health and education, with specific Assistance Listings related to cancer treatment, detection, diagnosis, control, cause and prevention, and biology research.